mdlinx mdlinx

Psychiatry - Neuro/Psych Pharmacol News & Articles

MDLinx Psychiatry is your one-stop shop for the peer-reviewed journal articles published in your field. We sort, rank and summarize the literature within 24 hours – hot off the presses! – so you can stay current without drowning in those piles of Current Psychiatry, Bipolar Disorders, and American Journal of Psychiatry. Also find bonus content like clinical pearls from The Smartest Psychiatrist Physician Review and daily quiz competition. Not sure where to start? Skim some of the recent “must read” articles highlighted by our own physician editor D. Scott Cunningham, MD, PhD.

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Articles

Latest (2) Full Text Articles (87) Focus on Substance Abuse
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

701 The diagnosis of depression and use of antidepressants in nursing home residents with and without dementia International Journal of Geriatric Psychiatry, May 18, 2012    Clinical Article

702 Antipsychotic use and diagnosis of delirium in the intensive care unit Critical Care, May 18, 2012

703 Plasma levels of milnacipran and its effectiveness for the treatment of chronic pain in the orofacial region Human Psychopharmacology: Clinical and Experimental, May 18, 2012    Clinical Article

704 The lipid profiles in Japanese patients with schizophrenia treated with antipsychotic agents General Hospital Psychiatry, May 18, 2012    Clinical Article

705 Effective connectivity of AKT1-mediated dopaminergic working memory networks and pharmacogenetics of anti-dopaminergic treatment Full Text Brain, May 18, 2012    Clinical Article

706 Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images Journal of Psychopharmacology, May 18, 2012    Clinical Article

707 Venlafaxin-Associated Post-Ictal Asystole during Electroconvulsive Therapy Pharmacopsychiatry, May 18, 2012    Clinical Article

708 Different safety profiles of risperidone and paliperidone extended-release: a double-blind, placebo-controlled trial with healthy volunteers Human Psychopharmacology: Clinical and Experimental, May 17, 2012    Clinical Article

709 Lack of Interaction between Sertraline and Lamotrigine in Psychiatric Patients: A Retrospective Study Pharmacopsychiatry, May 17, 2012    Clinical Article

710 The Differential Effect of Risperidone and Olanzapine on Insulin Sensitivity after 3 Weeks of Treatment: A HOMA Pilot Study Pharmacopsychiatry, May 17, 2012    Clinical Article

711 Psychosis from a Bath Salt Product Containing Flephedrone and MDPV with Serum, Urine, and Product Quantification Journal of Medical Toxicology, May 17, 2012

712 Antipsychotic polypharmacy in a regional health service: a population-based study Full Text BMC Psychiatry, May 16, 2012    Clinical Article

713 Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors Biological Psychiatry, May 16, 2012    Clinical Article

714 Vasculopathy Related to Manic/Hypomanic Symptom Burden and First-Generation Antipsychotics in a Sub-Sample from the Collaborative Depression Study Psychotherapy and Psychosomatics, May 16, 2012    Clinical Article
Exclusive Author Commentary

715 Debate continues over the use of combination antidepressants in patients with treatment-resistant depression Drugs & Therapy Perspectives, May 16, 2012    Clinical Article

716 Influence of acute bupropion pre-treatment on the effects of intranasal cocaine Addiction, May 15, 2012    Clinical Article

717 Baseline mood-state measures as predictors of antidepressant response to scopolamine Psychiatry Research, May 14, 2012    Clinical Article

718 Effects of Varenicline on Abstinence and Smoking Reward Following a Programmed Lapse Nicotine & Tobacco Research, May 14, 2012    Clinical Article

719 Rapid response to fluoxetine in women with premenstrual dysphoric disorder Depression and Anxiety, May 14, 2012    Clinical Article

720 Association of Nerve Growth Factor and Vascular Endothelial Growth Factor A with Psychometric Measurements of Opiate Dependence: Results of a Pilot Study in Patients Participating in a Structured Diamorphine Maintenance Program European Addiction Research, May 14, 2012    Clinical Article

50 available pages First Previous 36 37 38 39 40 41 42 43 44 45 Next Last

Clinical Pearls in Psychiatry

Highlights in Psychiatry

Risk factors for postpartum depression

As published in the American Journal of Obstetrics and Gynecology, risk factors for postpartum depression among abused women included age 15-19 (aOR=2.29) and > 35 years of age (aOR=2.33). In non-abused women, risk factors for postpartum depression include unemployment (aOR=1.41), foreign birth (aOR=2.04), and low income (aOR=1.68). Postpartum depression was also associated with women abused prior to pregnancy (aOR=3.28), abuse beginning postpartum (aOR=4.76), and abuse resuming postpartum (aOR=3.81).

Read the article summary

A link between cardiovascular fitness and depression

As published in the British Journal of Psychiatry, low cardiovascular fitness at 18 years of age (n = 1,117,292; follow-up, 3-40 y) is associated with an increased risk of severe depression (HR = 1.96).

Read the article summary

Optimal dose of amisulpride for acute exacerbation of schizophrenia

As published in Clinical Drug Investigation, an initial amisulpride dose of 800 mg (n=38) is more effective that 400 mg with dose titration (n=30) in patients with an acute exacerbation of schizophrenia. A greater number of patients in the 800 mg group than the 400 mg with dose titration group had a 30% reduction in the Positive and Negative Symptom Scale after 4 (68.4% vs. 40.0%) and 6 weeks (71.1% vs. 43.3%).

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Psychiatry Articles

Last month's top read Top Articles of 2012

1 Nidotherapy for people with schizophrenia Cochrane Reviews, April 11, 2013    Evidence Based Medicine

2 Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 13, 2013    Evidence Based Medicine

3 Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia International Clinical Psychopharmacology, April 25, 2013

4 Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study Neuropsychiatric Disease and Treatment, April 18, 2013    Free full text

5 Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study Schizophrenia Research, April 16, 2013

6 A randomized add-on trial of high-dose d -cycloserine for treatment-resistant depression International Journal of Neuropsychopharmacology, March 6, 2013

7 Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies Journal of Psychopharmacology, April 8, 2013

8 The sertraline versus electrical current therapy for treating depression clinical study (SELECT-TDCS): results of the crossover and follow-up phases Depression and Anxiety, April 29, 2013

9 Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials European Archives of Psychiatry and Clinical Neuroscience, April 22, 2013    Evidence Based Medicine

10 A Randomized Trial on the Acute and Steady-State Effects of a New Antidepressant, Vortioxetine, on Actual Driving and Cognition Clinical Pharmacology & Therapeutics, April 24, 2013

11 Guidance for the Discontinuation or Switching of Antidepressant Therapies in Adults Journal of Pharmacy Practice, March 26, 2013    Clinical Guideline

12 The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial Schizophrenia Research, April 17, 2013

13 A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence European Neuropsychopharmacology, April 12, 2013

14 Reboxetine Treatment for Autistic Spectrum Disorder of Pediatric Patients With Depressive and Inattentive/Hyperactive Symptoms: An Open-Label Trial Clinical Neuropharmacology, April 5, 2013

15 Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression Human Psychopharmacology: Clinical and Experimental, March 28, 2013

16 Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only Journal of Psychiatric Research, April 15, 2013

17 Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial International Journal of Neuropsychopharmacology, April 2, 2013
Exclusive Author Commentary

18 Asenapine effects on individual Young Mania Rating Scale items in bipolar disorder patients with acute manic or mixed episodes: a pooled analysis Neuropsychiatric Disease and Treatment, April 9, 2013    Free full text

19 The Fetal Safety of Fluoxetine: A Systematic Review and Meta-Analysis Journal of Obstetrics and Gynaecology Canada, April 11, 2013    Free full text    Evidence Based Medicine    Review Article

20 A double-blind, placebo-controlled study of adjunctive calcitonin nasal spray in acute refractory mania Bipolar Disorders, April 2, 2013

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Other Topics in Psychiatry

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close